Merck’s COVID-19 Pill Shows Significantly Lower Efficacy in Updated Data

Merck & Co said on Friday updated data from its study on its experimental COVID-19 pill showed the drug was significantly less effective in cutting hospitalizations and deaths than previously reported. Read More